Showing results (201-210 of 345) with videos related to

Sort By:
Pageof 35
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2022
Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 PandemicThao Doan, Fabio Lievano, Linda Scarazzini, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 30, 2018
Edoxaban for Venous Thromboembolism Treatment-The New Kid on The Block for Latin America. A Practical GuideEduardo Ramacciotti, Valéria Cristina Resende Aguiar, Valter Castelli Júnior, et al.
Blood|March 6, 2002
Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosisVijay V Kakkar, Debra A Hoppenstead, Jawed Fareed, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 8, 2009
The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activityCinara L Echart, Barbara Graziadio, Simona Somaini, et al.
Seminars in Thrombosis and Hemostasis|April 9, 2008
Survival of heparins, oral anticoagulants, and aspirin after the year 2010Jawed Fareed, Debra A Hoppensteadt, Daniel Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2019
Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment ValuesFakiha Siddiqui, Alfonso Tafur, Lorenzo Storino Ramacciotti, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 20, 2012
Left ventricular assist device-induced coagulation and platelet activation and effect of the current anticoagulant therapy regimenMichael Ashbrook, Jeanine M Walenga, Jeffrey Schwartz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 20, 2013
Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopeniaJeanine M Walenga, Margaret Prechel, Debra Hoppensteadt, et al.
Analytical Chemistry|July 21, 2015
Differentiation of generic enoxaparins marketed in the United States by employing NMR and multivariate analysisMarco Guerrini, Timothy R Rudd, Lucio Mauri, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 12, 2022
Arterial-renal Syndrome in Patients with ESRD, a New Disease ParadigmJake Goldstein, Robert S Dieter, Vinod Bansal, et al.
Pageof 35